Is ESAIY or VYM a better dividend investment in 2026?

ESAIY currently yields 3.13% with a 5% 5-year dividend growth rate. VYM yields 2.37% with 7.8% growth. The better choice depends on your goal: ESAIY offers higher current income.

What is the dividend yield difference between ESAIY and VYM?

ESAIY has a forward dividend yield of 3.13% ($0.24/share annually). VYM yields 2.37% ($3.51/share annually). The yield gap is 0.76 percentage points.

Home › Compare › ESAIY vs VYM

ESAIY vs VYM: Dividend Comparison 2026

ESAIY yields 3.13% · VYM yields 2.37%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VYM wins by $3.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ESAIY

● Live price

3.13%

Share price

$7.66

Annual div

$0.24

5Y div CAGR

0.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.6K

Annual income

$400.49

Full ESAIY calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.37%

Share price

$148.10

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$272.94

Full VYM calculator →

Portfolio growth — ESAIY vs VYM

📍 VYM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ESAIY	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ESAIY + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ESAIY pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESAIY

Annual income on $10K today (after 15% tax)

$266.34/yr

After 10yr DRIP, annual income (after tax)

$340.42/yr

VYM

Annual income on $10K today (after 15% tax)

$201.60/yr

After 10yr DRIP, annual income (after tax)

$232.00/yr

At 15% tax rate, ESAIY beats the other by $108.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESAIY + VYM for your $10,000?

ESAIY: 50%VYM: 50%

100% VYM50/50100% ESAIY

Portfolio after 10yr

$26.2K

Annual income

$336.72/yr

Blended yield

1.29%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESAIY buys

VYM buys

No recent congressional trades found for ESAIY or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricESAIYVYM

Forward yield	3.13% ✓	2.37%
Annual dividend / share	$0.24	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0.4% ✓	0%
Portfolio after 10y	$24.6K	$27.8K ✓
Annual income after 10y	$400.49 ✓	$272.94
Total dividends collected	$3.6K ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ESAIY vs VYM ($10,000, DRIP)

Year	ESAIY Portfolio	ESAIY Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$11,015	$314.60	$11,147	$237.17	$132.00 → VYM
2	$12,111	$325.14	$12,404	$242.33	$293.00 → VYM
3	$13,294	$335.45	$13,780	$247.16	$486.00 → VYM
4	$14,570	$345.51	$15,285	$251.67	$715.00 → VYM
5	$15,945	$355.31	$16,932	$255.88	$987.00 → VYM
6	$17,426	$364.87	$18,733	$259.81	$1.3K → VYM
7	$19,020	$374.16	$20,701	$263.46	$1.7K → VYM
8	$20,735	$383.19	$22,852	$266.86	$2.1K → VYM
9	$22,578	$391.97	$25,201	$270.01	$2.6K → VYM
10	$24,559	$400.49	$27,768	$272.94	$3.2K → VYM

ESAIY vs VYM: Complete Analysis 2026

ESAIY — Stock

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Full ESAIY Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this ESAIY vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESAIY vs SCHD ESAIY vs JEPI ESAIY vs O ESAIY vs KO ESAIY vs MAIN ESAIY vs VIG ESAIY vs DGRO ESAIY vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.